Combination platinum chemotherapeutic/antiestrogen therapy for human cancers
AssigneeResearch Development Foundation
InventorsEdward F. McClay, Stephen B. Howell, Gerrit Los
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition of matter for the treatment of non-melanoma cancers, wherein said composition comprises a platinum anti-neoplastic compound and tamoxifen, wherein said platinum anti-neoplastic compound and tamoxifen exert a synergistic anti-tumor effect on said non-melanoma cancer. Also provided are various methods of treating non-melanoma cancers and methods of preventing or overcoming resistance to platinum-containing anti-neoplastic compounds.
Claims1
A method of overcoming resistance to cisplatin in an individual having a neoplastic disease comprising administering tamoxifen to said individual, wherein said disease is selected from the group consisting of melanoma, ovarian carcinoma, small cell lung carcinoma, testicular cancer, bladder cancer and squamous cell cancer of the head and neck and wherein and said tamoxifen is administered in an amount of from about 0.1 .mu.M to about 1.0 .mu.M without treating the disease per se.
Dependencies are inferred from the claim text.